Wednesday, December 17, 2025
Home Authors Posts by Ogkologos

Ogkologos

4097 POSTS 0 COMMENTS

Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid...

Ogkologos -
0

A Combination of Talazoparib and Enzalutamide Prolongs OS in Unselected and...

Ogkologos -
0

ESMO Recommendations on Cancer Care Reflected in Un ECOSOC Ministerial Declaration...

Ogkologos -
0

FDA Grants Accelerated Approval to Linvoseltamab-gcpt for Relapsed or Refractory Multiple...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Darolutamide

Ogkologos -
0

Savolitinib Plus Osimertinib Show a High Response in EGFR-mutated NSCLC Progressed...

Ogkologos -
0

2025 ESMO Society Award recipients announced

Ogkologos -
0

Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Ogkologos -
0

A Combination of Avutometinib Plus Defactinib Results in Clinically Meaningful Benefit...

Ogkologos -
0

OS Benefit from TTFields with Gemcitabine/Nab-paclitaxel for Patients with Unresectable Locally...

Ogkologos -
0
1...121314...410Page 13 of 410

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com